There will be a meeting next week at the National Cancer Institute (NCI) dedicated to pediatric cancer drug development. The National Cancer Institute (NCI) will hold its 64th Meeting of the Director’s Consumer Liaison Group (DCLG) on Friday, February 21, 2014 from 9:30 a.m. to 4:00 p.m. on the National Institutes of Health (NIH) Campus in Bethesda, MD. The meeting will focus on barriers to drug development in pediatric cancer research and will include participants from the pediatric cancer advocacy community, as well as private and public sector presenters. The panels will discuss the State of Pediatric Cancer Research, Potential […]
Read moreAll posts tagged: Advocacy
Protected: CAC2 Advocacy Conference Call Notes from February 4
There is no excerpt because this is a protected post.
Read moreProtected: REMINDER: February CAC2 Advocacy Conference Call
There is no excerpt because this is a protected post.
Read moreProtected: Advocates Conference Call
There is no excerpt because this is a protected post.
Read more
CAC2 Member Blog–Childhood Cancer Advocacy and Direction: The Tail Wagging the Dog
By CAC2 Individual Member Jonathan Agin Lately, I have wondered whether or not the childhood cancer community is on the right track overall. By this, I mean, is the direction of the community in terms of raising money, awareness and the manner of funding research the best approach as a whole? I honestly do not know. I raise the question to suggest simply that it may not be and thus, a hard conversation and internal focus might be necessary. Despite the false and misleading suggestion that is presented by the message that 80 to 85 percent of all children diagnosed […]
Read more